Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 6/20 | 0.77 |
| ▸ | MMP9 | P14780 | 6/20 | 0.77 |
| ▸ | MMP3 | P08254 | 3/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MMP13 | P45452 | 2/20 | 0.51 |
| ▸ | MMP8 | P22894 | 1/20 | 0.49 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenobarbital SCHEMBL23494821 | 0.98 | MMP2 (0.75) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL2592325 | 0.98 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL16583 | 0.98 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL28099657 | 0.98 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL18825042 | 0.98 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL6807467 | 0.96 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL352763 | 0.96 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL22032658 | 0.96 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL1322895 | 0.96 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL3475428 | 0.96 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024048643-A1 | EXOSOME PRODUCTION METHOD | 東洋紡株式会社 | 2024-03-07 | — | — | WO | disclosed |
| US-10940235-B2 | Biocompatible implants for nerve re-generation and methods of use thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-03-09 | — | — | US | disclosed |
| US-10405963-B2 | Method of producing a 3D subject specific biomimetic nerve conduit | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2019-09-10 | — | — | US | disclosed |
| US-20180280567-A1 | BIOCOMPATIBLE IMPLANTS FOR NERVE RE-GENERATION AND METHODS OF USE THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2018-10-04 | — | — | US | disclosed |
| EP-3283137-A1 | BIOCOMPATIBLE IMPLANTS FOR NERVE RE-GENERATION AND METHODS OF USE THEREOF | Rutgers, The State University of New Jersey (US) | 2018-02-21 | — | — | EP | disclosed |
| US-20170135802-A1 | 3D PRINTED PATIENT-SPECIFIC CONDUITS FOR TREATING COMPLEX PERIPHERAL NERVE INJURY | THE TRUSTEES OF PRINCETON UNIVERSITY | 2017-05-18 | — | — | US | disclosed |
| WO-2016168669-A1 | BIOCOMPATIBLE IMPLANTS FOR NERVE RE-GENERATION AND METHODS OF USE THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-10-20 | — | — | WO | disclosed |
| US-20090233888-A1 | TREATMENT OF DISEASE CONDITIONS THROUGH MODULATION OF HYDROGEN SULFIDE PRODUCED BY SMALL INTESTINAL BACTERIAL OVERGROWTH | USC STEVENS, UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-09-17 | — | — | US | disclosed |
| WO-2006102536-A2 | TREATMENT OF DISEASE CONDITIONS THROUGH MODULATION OF HYDROGEN SULFIDE PRODUCED BY SMALL INTESTINAL BACTERIAL OVERGROWTH | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2006-09-28 | — | — | WO | disclosed |